Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,181 | 50,895 | 70,495 | 92,136 | 77,264 |
| Marketable Securities | N/A | N/A | N/A | 2,042 | 76,276 |
| Receivables | N/A | N/A | N/A | 15,345 | 9,604 |
| Inventories | N/A | N/A | N/A | 8,639 | 5,229 |
| Other current assets | 0 | 0 | 7,595 | 0 | 0 |
| TOTAL | $52,797 | $52,870 | $85,942 | $124,366 | $171,379 |
| Non-Current Assets | |||||
| PPE Net | 749 | 753 | 400 | 2,722 | 3,166 |
| Other Non-Current Assets | 1,937 | 2,326 | 478 | 12,339 | 47,061 |
| TOTAL | $2,686 | $3,079 | $878 | $15,061 | $50,227 |
| Total Assets | $55,483 | $55,949 | $86,820 | $139,427 | $221,606 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,336 | N/A | 9,741 | 10,826 | N/A |
| Accounts payable and accrued liabilities | 628 | 919 | 2,832 | 4,899 | 1,724 |
| Accrued Expenses | 4,975 | 6,018 | 8,910 | 20,986 | 18,971 |
| TOTAL | $16,956 | $8,346 | $25,685 | $37,422 | $22,225 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,761 | 38,300 | 42,161 | 84,653 | 72,243 |
| Deferred Revenues | 637 | 1,075 | 4,189 | N/A | N/A |
| Other Non-Current Liabilities | 1,434 | 1,799 | 0 | 548 | 27,143 |
| TOTAL | $26,195 | $40,099 | $42,161 | $85,201 | $99,386 |
| Total Liabilities | $43,151 | $48,445 | $67,846 | $122,623 | $121,611 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,452 | 2,816 | 2,025 | 1,452 | 1,231 |
| Common Shares | 6 | 3 | 2 | 1 | 59 |
| Retained earnings | -667,920 | -629,409 | -587,210 | -542,388 | -399,783 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 4 |
| TOTAL | $12,332 | $7,504 | $18,974 | $16,804 | $99,995 |
| Total Liabilities And Equity | $55,483 | $55,949 | $86,820 | $139,427 | $221,606 |